
Pharma Pulse 7/4/24: Colder Temperatures May Worsen Asthma Symptoms, New FDA Approved ALZ Drug to Accelerate New Era of Treatment & more
The latest news for pharma industry insiders.
Preliminary results from study of small interfering RNA drug candidate, STP707, indicated the average days for stable disease in patients was 92.
However, more research is needed to effectively integrate this biomarker into individualized asthma management strategies for pediatric patients.
With the arrival of Lilly’s Kisunla, Alzheimer’s care could become more like treatment of cancer and rheumatoid arthritis and their regular infusions.
Boys & Girls Clubs of America, in collaboration with Kohl’s, hosted a mental health panel and discussion about challenges young people face, featuring actor, musician and dancer Jacob Latimore and youth from Atlanta-area Boys & Girls Clubs. The event on June 29 culminated National Boys & Girls Club Week celebrations and provided a platform for young people to engage in open, authentic conversations about mental health challenges and successes experienced within different communities.
The 4th of July is the day of the year that pets are most likely to go missing.
Loud sounds, crowds, and flashing lights may contribute to overwhelming anxiety that can make pets run away.
If you can’t keep your pet inside during the fireworks, make sure they have ID tags and are microchipped in case they run away in the chaos.
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor 
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

